申请人:Gilead Sciences Drive
公开号:US20170007617A1
公开(公告)日:2017-01-12
An intravenous pharmaceutical composition or kit comprising 4-(pyrimidin-2-ylmethyl)-7-(4-(trifluoromethoxy)phenyl)-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one (Compound I) and a beta-cyclodextrin derivative.